Inflammation, which is initiated and perpetuated by microorganism pathogens or from the damage or death of host cells, is an essential component of various respiratory diseases. Although distinct inflammatory responses contribute to different diseases, some common features are shared. For example, macrophages, an important immune cell against TB, have been thought to valiantly fight a losing battle against aggressive cancers; on the other hand, they are the culprits in COPD and can be manipulated to work for tumours in the tumour microenvironment. Knowledge and understanding of the possible mechanisms and pathways underlying the inflammatory responses have led to the development of therapy and drug designs leading to better clinical care to patients.

We invite authors to submit original research articles and review articles that will stimulate the continuing efforts to understanding the molecular biology and pathology underlying inflammatory lung disease, the development of strategies for pulmonary treatment and rehabilitation, and the evaluation of outcomes. We are also interested in articles that explore aspects of potential risk factors in the development of inflammatory lung disease.

Potential topics include, but are not limited to:

• Recent developments/opinions in lung disease research and treatment
• Last technologies for clinical evaluation and measuring outcomes
• Roles of inflammation in chronic obstructive pulmonary disease
• Roles of inflammation in lung cancer
• Roles of inflammation in mycobacterium tuberculosis
• Roles in pulmonary rehabilitation in inflammatory lung disease
• Risk factors for inflammatory lung disease